Biotech Startups

Ashish Life Science Pvt Limited manufactures veterinary and animal health pharmaceutical products, serving customers worldwide. Part of the Ashish Group of Industries, it operates a GMP-compliant manufacturing facility for its animal health product range.

1 investor

Ashlins Pharmaceuticals develops therapeutics for rare and underserved diseases, focusing on programs with scientific validation and accelerated regulatory pathways to deliver treatments where patient options are limited.

1 investor

1 investor

Asieris (亚虹医药) is a pharmaceutical company developing diagnostic and therapeutic products focused on women's reproductive health and urologic cancers, including treatments for cervical precancerous lesions and bladder cancer. Its portfolio includes a non-invasive portable cervical photodynamic therapy product and a blue-light cystoscopy system for bladder cancer diagnosis, marketed in China.

1 investor

Asima Health is developing a non-invasive, multi-cancer blood test that uses a pan-genomic platform to detect multiple cancers from a single blood draw. The portable technology is intended for use through local diagnostic labs as part of routine blood work to identify people at risk who may need further screening.

1 investor

Asimov builds a computer-aided design platform for genetic engineering and synthetic biology, enabling genetic designers to program living cells through automated circuit design and computational modeling.

1 investor

Asius Technologies develops ADEL® (Ambrose Diaphonic Ear Lens), a patented "second eardrum" technology for professional in-ear monitors and earbuds that absorbs in-ear pneumatic pressure to reduce the risk of hearing damage while delivering higher-fidelity sound. The company also publishes research on AI, quantum computing, and epistemology.

1 investor

AskAt is a pharmaceutical company focused on developing new drugs with novel mechanisms for conditions that lack effective treatments, such as cancer, dementia, and autoimmune diseases. It aims to bring these therapies to patients worldwide.

1 investor

Aspen Biosciences provides consulting, advisory, and research resources focused on drug discovery and biopharmaceutical R&D, serving pharmaceutical and biotech companies navigating program management, digital transformation, and emerging technologies like AI.

1 investor

AspiAir is a clinical-stage biotech company developing LASAG Inhale, an inhaled non-opioid treatment for pain and migraine attacks using acetylsalicylic acid. The company serves patients in the EU who lack access to adequate migraine medications and aims to provide a safe, mobile alternative to current therapies.

1 investor

AviadoBio is a biotech company focused on frontotemporal dementia (FTD), a form of early-onset dementia. The company engages with patients, families, and caregivers affected by FTD to develop treatment solutions.

1 investor

Aspire Pharma is a UK-based pharmaceutical company, founded in 2009, that develops and markets niche generic and branded medicines across therapy areas including urology, CNS, respiratory, ophthalmology and dermatology. It is expanding across Europe, with entities in Ireland and Germany, and grows through acquisitions and licensing deals.

1 investor

iAssist is a specialty therapy initiation platform that helps patients access prescribed therapies by reducing administrative delays and improving communication between patients, healthcare providers, and manufacturers. The platform serves nurses, healthcare practices, and oncology drug manufacturers in the specialty pharmaceutical sector.

1 investor

AssureDrop develops droplet microfluidics-based screening technology that works within standard multiwell plates for pipette-free, high-throughput screening of 3D cell models such as spheroids. It targets biotechnology and cancer research applications including drug discovery, personalized medicine, and genetic analysis using limited biological samples like patient biopsies and stem cells.

1 investor

Aston Particle Technologies develops the iDPC (dry particle coater) technology for pharmaceutical and biotechnology companies to support drug formulation and development. The company serves the pharmaceutical and biotechnology sectors with forward-thinking scientific solutions.

1 investor

Astraea provides clinical trial automation software for pharmaceutical sponsors that uses AI to automate post-protocol tasks including statistical analysis plans, case report forms, datasets, regulatory documentation, and FDA submissions. The platform is deployed within the sponsor's own environment to maintain data security and compliance across oncology, rare disease, and medical devices.

1 investor

Astratus develops a semi-automated laboratory platform using a microcapillary "dip and test" cassette and instrument reader for rapid antimicrobial susceptibility testing (AST), delivering results in under 6 hours directly from urine or bacterial isolates. It serves human, veterinary, and research markets, supporting clinical laboratories with antimicrobial stewardship and researchers developing new antimicrobials and therapies.

1 investor

Astraveus develops the Lakhesys Benchtop Cell Factory, a microfluidic-based bioprocessing platform for scaling cell and gene therapy manufacturing with improved quality and cost efficiency. The company serves biotech and pharma organizations working on cell therapy manufacturing and commercialization.

1 investor

Atanis Biotech develops FAST-PASE®, a blood-based allergy diagnostic test that measures how a patient's blood activates mast cells in response to specific food and other allergens, avoiding skin pricks and food challenges. The test targets common food allergens (egg, milk, peanut, cashew) and Alpha-gal red meat allergy, and is currently in development for use by patients and healthcare providers.

1 investor

Atelerix Life Sciences develops novel respiratory therapies for drug-induced respiratory depression, respiratory disease exacerbations, and bio-defense against respiratory threats. The company is advancing pre-clinical and clinical-stage drug candidates, with ATLX-0199 as its lead compound designed to stimulate respiratory drive while preserving pain relief and sedation.

1 investor

Ateria Health is a health and wellness company focused on gut microbiome health, developing products based on proprietary enzyme research to address conditions like irritable bowel syndrome. The company targets consumers seeking dietary supplements and health interventions related to digestive and metabolic health.

1 investor

ATG Therapeutics develops small molecule anti-cancer drug candidates targeting advanced cancer, with proprietary biomarker and patient selection technology.

1 investor

Athaca provides AI-driven solutions for clinical trial management, including synthetic patient cohort generation for rare diseases, intelligent data quality analysis, and protocol design risk assessment. The platform operates in regulated healthcare environments with emphasis on data privacy, auditability, and compliance.

1 investor

1 investor